Shyam Kambeyanda - Oct 15, 2021 Form 4 Insider Report for Colfax CORP (ENOV)

Role
ESAB President and EVP, Colfax
Signature
/s/ Bradley Tandy, Attorney-in-Fact
Stock symbol
ENOV
Transactions as of
Oct 15, 2021
Transactions value $
-$1,405,409
Form type
4
Date filed
10/19/2021, 06:00 PM
Next filing
Dec 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENOV Common stock, par value $.001 Options Exercise $615K +24.6K +26.63% $24.96 117K Oct 15, 2021 Direct
transaction ENOV Common stock, par value $.001 Sale -$1.25M -24.6K -21.03% $50.69 92.5K Oct 15, 2021 Direct F1, F2
transaction ENOV Common stock, par value $.001 Sale -$771K -15.2K -16.44% $50.68 77.3K Oct 15, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENOV Employee Stock Option (right to buy) Options Exercise $0 -24.6K -100% $0.00* 0 Oct 15, 2021 Common stock, par value $.001 24.6K $24.96 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.04 to $51.04, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.05 to $51.03, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4 The option vests in equal installments on the first, second and third anniversaries of the grant date, which was 5/13/2016.